lntraarticular Injections: Persistent inflammation in one or several joints after general treatment of chronic inflammatory joint diseases; arthritis in pseudogout/chondrocalcinosis; active osteoarthritis; post-traumatic, non-bacterial arthritis.
Infiltration therapy: Non-bacterial tendovaginitis (only when strictly indicated) and bursitis; periathropathy; insertional tendinopathy; enthesopathy in systemic, inflammatory rheumatic disease.
Sub- and Intralesional Injection: Isolated foci of psoriasis; lichen ruber planus, lichen simplex chronicus (neurodermatitis circumscripta); alopecia areata; chronic discoid lupus erythematosus; keloids.